Showing 1 - 10 of 385
This paper reconsiders the equity issue in Swedish health care utilisation previously analyzed by Gerdtham (Health Economics 6, 303-319, 1997) within the framework of the standard two-part model. Departing from the user/nonuser distinction, we use the more flexible framework of the finite...
Persistent link: https://www.econbiz.de/10005649172
Persistent link: https://www.econbiz.de/10001464608
Persistent link: https://www.econbiz.de/10000780861
Persistent link: https://www.econbiz.de/10001136143
Persistent link: https://www.econbiz.de/10002105864
Persistent link: https://www.econbiz.de/10001657940
Persistent link: https://www.econbiz.de/10001493853
Persistent link: https://www.econbiz.de/10000943020
Persistent link: https://www.econbiz.de/10000823261
SUMMARY In this paper, we estimate a copula‐based bivariate dynamic hurdle model of prescription drug and nondrug expenditures to test the cost‐offset hypothesis, which posits that increased expenditures on prescription drugs are offset by reductions in other nondrug expenditures. We apply...
Persistent link: https://www.econbiz.de/10011202180